BSECompany Update12 Oct 2026 · 12 Oct 2026, 11:44 am

Please find attached intimation regarding Earnings Conference Call for Q2 & H1 FY27.

Mankind Pharma Ltd · 543904

✦ AI SummaryResults

Mankind Pharma Ltd has announced an earnings conference call for Q2 & H1 FY27 on October 26, 2026, to discuss the company's business and financial results.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

11be815c-9f72-46a2-a6a1-3629261d6d9f.pdf

pdf

Download →

View document text

October 12, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Sub.: Intimation of Earnings Conference Call for Q2 & H1 FY27 Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject, we wish to inform you that the management of the Company will host an earnings conference call on Monday, October 26, 2026, at 06:00 P.M. (IST), to discuss the business and financial results of the Company for Q2 & H1 FY27. Please find the link for the earnings conference call: Q2 & H1 FY27 Earnings Conference Call Above information is also available on the website of the Company at www.mankindpharma.com. Kindly take the same on record. Thanking you Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer